These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 22748194)
1. The diagnostic utility of cardiac biomarkers in dialysis patients. Wang AY; Wai-Kei Lam C Semin Dial; 2012 Jul; 25(4):388-96. PubMed ID: 22748194 [TBL] [Abstract][Full Text] [Related]
2. Use of cardiac biomarkers in end-stage renal disease. Wang AY; Lai KN J Am Soc Nephrol; 2008 Sep; 19(9):1643-52. PubMed ID: 18322158 [TBL] [Abstract][Full Text] [Related]
3. Cardiac biomarkers in haemodialysis patients: the prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin T. Sommerer C; Giannitsis E; Schwenger V; Zeier M Nephron Clin Pract; 2007; 107(3):c77-81. PubMed ID: 17890874 [TBL] [Abstract][Full Text] [Related]
4. How does volume status affect BNP and troponin levels as markers of cardiovascular status in peritoneal dialysis? Garg R; Singh A; Khaja A; Martin A; Aggarwal K Congest Heart Fail; 2009; 15(5):240-4. PubMed ID: 19751426 [TBL] [Abstract][Full Text] [Related]
5. Clinical utility of natriuretic peptides in dialysis patients. Wang AY Semin Dial; 2012 May; 25(3):326-33. PubMed ID: 22607214 [TBL] [Abstract][Full Text] [Related]
6. Understanding cardiac biomarkers in end-stage kidney disease: Frequently asked questions and the promise of clinical application. Roberts MA; Hedley AJ; Ierino FL Nephrology (Carlton); 2011 Mar; 16(3):251-60. PubMed ID: 21342319 [TBL] [Abstract][Full Text] [Related]
7. [Brain natriuretic peptide (BNP) and N-terminal-pro BNP in chronic haemodialysed renal failure]. Bertinchant JP Arch Mal Coeur Vaiss; 2004 Sep; 97(9):881-8. PubMed ID: 15521481 [TBL] [Abstract][Full Text] [Related]
8. Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients. Hickman PE; McGill DA; Talaulikar G; Hiremagalur B; Bromley J; Rahman A; Koerbin G; Southcott E; Potter JM Intern Med J; 2009 Dec; 39(12):812-8. PubMed ID: 20233242 [TBL] [Abstract][Full Text] [Related]
9. Biomarkers for the prediction of mortality and morbidity in patients with renal replacement therapy. Chaykovska L; Tsuprykov O; Hocher B Clin Lab; 2011; 57(7-8):455-67. PubMed ID: 21888009 [TBL] [Abstract][Full Text] [Related]
10. [Clinical utility of the cardiac markers BNP and NT-proBNP]. Buchner S; Riegger G; Luchner A Acta Med Austriaca; 2004; 31(4):144-51. PubMed ID: 15732251 [TBL] [Abstract][Full Text] [Related]
11. Role of renal function and cardiac biomarkers (NT-proBNP and Troponin) in determining mortality and cardiac outcome in atheromatous renovascular disease. Chrysochou C; Manzoor S; Wright J; Roberts SA; Wood G; McDowell G; Kalra PA Kidney Blood Press Res; 2009; 32(5):373-9. PubMed ID: 19887825 [TBL] [Abstract][Full Text] [Related]
12. Biomarkers in acute cardiovascular disease. Howie-Esquivel J; White M J Cardiovasc Nurs; 2008; 23(2):124-31. PubMed ID: 18382255 [TBL] [Abstract][Full Text] [Related]
13. The impact of dialysis type on biomarkers for cardiovascular diseases. Sahinarslan A; Güz G; Mutluay R; Okyay K; Demirtaş C; Paşaoğlu H; Yalçın R Turk Kardiyol Dern Ars; 2011 Sep; 39(6):456-62. PubMed ID: 21918314 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients. Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403 [TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients. Wang AY; Lam CW; Yu CM; Wang M; Chan IH; Zhang Y; Lui SF; Sanderson JE J Am Soc Nephrol; 2007 Jan; 18(1):321-30. PubMed ID: 17167121 [TBL] [Abstract][Full Text] [Related]
16. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic, prognostic, and therapeutic implications of brain natriuretic peptide in dialysis and nondialysis-dependent chronic renal failure. Mark PB; Petrie CJ; Jardine AG Semin Dial; 2007; 20(1):40-9. PubMed ID: 17244121 [TBL] [Abstract][Full Text] [Related]
18. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. Zethelius B; Berglund L; Sundström J; Ingelsson E; Basu S; Larsson A; Venge P; Arnlöv J N Engl J Med; 2008 May; 358(20):2107-16. PubMed ID: 18480203 [TBL] [Abstract][Full Text] [Related]
19. Over time, high-sensitivity TnT replaces NT-proBNP as the most powerful predictor of death in patients with dialysis-dependent chronic renal failure. McGill D; Talaulikar G; Potter JM; Koerbin G; Hickman PE Clin Chim Acta; 2010 Jul; 411(13-14):936-9. PubMed ID: 20298685 [TBL] [Abstract][Full Text] [Related]
20. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure. Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]